Audio poster

Safety and longer-term efficacy of concizumab prophylaxis in patients with hemophilia A or B with inhibitors: Results from the extension part of the phase 2 explorer4 trial

Author
Shapiro AD, Castaman C, Cepo K, Tønder SM, Matsushita T, Poulsen LH, Young G, Zupancic-Šalek G, Jiménez-Yuste V
Citation
Amy D Shapiro, Giancarlo Castaman, Katarina Cepo, Sidsel Marie Tønder, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Guy Young, Silva Zupancic-Šalek, Victor Jimenez Yuste; Safety and Longer-Term Efficacy of Concizumab Prophylaxis in Patients with Hemophilia a or b with Inhibitors: Results from the Extension Part of the Phase 2 explorer4 Trial. Blood 2020; 136 (Supplement 1): 40–41. doi: https://doi.org/10.1182/blood-2020-139910
Date of Publication

This website is intended
for healthcare professionals (HCPs)
outside of the U.S.

Take me to www.novonordisk.com